Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor liver graft-derived NK cell adoptive immunotherapy after liver transplantation
jRCTa060190036Completed
- Start
- Mar 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in bloodstream infection (BSI). Primary endpoint: Incidence of bloodstream infection during one month after liver transplantation. Started Mar 2016; status: completed.
02
Conditions
bloodstream infection (BSI)
Beyond the preview
Go deeper on jRCTa060190036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTa060190036.